Modified Frailty Index-11 (mFI-11) measured frailty as a predictor of post-transplant outcomes in non-Hodgkin’s lymphoma patients undergoing hematopoietic stem cell transplantation: a retrospective analysis of National Inpatient Sample database
Supportive Care in Cancer · 2026-05 · 34 (5)
DOI: 10.1007/s00520-026-10711-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Supportive Care in Cancer, online erschienen am 04.05.2026. Verfasst von Abdul Hadi Khan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Jinnah Sindh Medical University, Karachi, 75510, Pakistan. hadik1073@gmail.com. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Lymphoma, Non-Hodgkin, Frailty. Die Arbeit nennt 29 Literaturangaben.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is a critical treatment for non-Hodgkin lymphoma (NHL) but involves significant post-transplant risks. Frailty, measured by the Modified Frailty Index-11 (mFI-11), may influence outcomes. METHODS: We analyzed NHL patients undergoing autologous or allogeneic HSCT from the Nationwide Inpatient Sample (2016-2020). Frailty was defined by mFI-11, and outcomes included in-hospital mortality, unfavorable discharge, prolonged length of stay (LOS), complications, and costs. Multivariable regression models with stratification by age and Charlson Comorbidity Index were applied. RESULTS: Of 2807 patients (ages 18-85), frail patients were older and had more comorbidities. In autologous HSCT, frailty was linked to higher mortality (2.02% vs. 0.27%, p < 0.001), increased unfavorable discharges (19.75% vs. 10.80%, p < 0.0001), and prolonged LOS (15.92% vs. 7.75%, p < 0.0001). Similar trends were observed in the allogeneic cohort. CONCLUSIONS: Frailty predicts worse post-transplant outcomes in NHL patients undergoing HSCT, emphasizing the need for pre-transplant frailty screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Jinnah Sindh Medical University, Karachi, 75510, Pakistan. hadik1073@gmail.com.
- School of Medicine and Health Sciences, Universidad del Rosario, 11321, Bogotá, Colombia.
- College of Medicine, Al-Faisal University, 11533, Riyadh, Saudi Arabia.
- Department of Medical Microbiology and Immunology, University of Toledo, Toledo, OH, 43606, USA.
- School of Public Health, Health Economics, and Health Services Research, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
- Department of Internal Medicine, University of Naples Federico II, 80138, Naples, Italy.
ORCID-Profile: Abdul Hadi Khan
Zitieren
APA
Khan, A. H., Diaz-Riaño, J. N., Ijaz, E., Olatunji, A. O., Al Zoubi, M. A. M., Altamimi, A., Fidelugwuowo, K. D., & Akhtar, S. O. (2026). Modified Frailty Index-11 (mFI-11) measured frailty as a predictor of post-transplant outcomes in non-Hodgkin’s lymphoma patients undergoing hematopoietic stem cell transplantation: a retrospective analysis of National Inpatient Sample database. Supportive Care in Cancer, 34(5). https://doi.org/10.1007/s00520-026-10711-0
Vancouver
Khan AH, Diaz-Riaño JN, Ijaz E, Olatunji AO, Al Zoubi MAM, Altamimi A, et al. Modified Frailty Index-11 (mFI-11) measured frailty as a predictor of post-transplant outcomes in non-Hodgkin’s lymphoma patients undergoing hematopoietic stem cell transplantation: a retrospective analysis of National Inpatient Sample database. Supportive Care in Cancer. 2026;34(5). doi:10.1007/s00520-026-10711-0
BibTeX
@article{Khan2026,
author = {Khan, Abdul Hadi and Diaz-Riaño, Juan Nicolás and Ijaz, Eman and Olatunji, Aliu Olalekan and Al Zoubi, Mohammad Ahmmad Mahmoud and Altamimi, Almothana and Fidelugwuowo, Kaodichimma Dickson and Akhtar, Syed Owais},
title = {Modified Frailty Index-11 (mFI-11) measured frailty as a predictor of post-transplant outcomes in non-Hodgkin’s lymphoma patients undergoing hematopoietic stem cell transplantation: a retrospective analysis of National Inpatient Sample database},
journal = {Supportive Care in Cancer},
year = {2026},
volume = {34},
number = {5},
doi = {10.1007/s00520-026-10711-0}
}
EUVIMED